newsfilter
← Latest News
Business Wire·

Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results

– Fourth Quarter 2023 Total Revenue of $48.3 Million and Full Year 2023 Revenue of $163.4 Million; QINLOCK® Net Product Revenue Increased 27% to $159.1 Million in 2023 Compared to 2022 – – Expects to Submit NDA